ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION USING DRUG-ELUTING STENTS IN PATIENTS WITH ATRIAL FIBRILLATION

Autor:	Yongjun Li, Guoping Shi, Lulu Sun, Jinchuan Yan, Xiang Wu, Rui Zhang, Jiyan Chen, Mingming Yang, Jianrong Yin, Shenghu He, Likun Ma, Zhirong Wang, Wenbin Lu, Zhongpu Chen, Yuyu Yao, Genshan Ma, Hesong Zeng, Li-Juan Chen, Yu Wang, Bing Han, Lianglong Chen
Rok vydání:	2020
Předmět:	Drug medicine.medical_specialty business.industry medicine.medical_treatment media_common.quotation_subject Percutaneous coronary intervention Atrial fibrillation medicine.disease surgical procedures operative Internal medicine Antithrombotic medicine Cardiology In patient cardiovascular diseases Cardiology and Cardiovascular Medicine business media_common
Zdroj:	Journal of the American College of Cardiology. 75:121
ISSN:	0735-1097
Popis:	Long-term anticoagulation is recommended for atrial fibrillation (AF) patients with CHA2DS2VASc score ≥ 2. Antiplatelet therapy is also necessary when these patients undergo percutaneous coronary intervention with drug-eluting stents (PCI-eS). But the antithrombotic regimens for these patients
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::47396415efc05bb4264ff335a326d349 https://doi.org/10.1016/s0735-1097(20)30748-8 Zobrazit plný text záznamu